The resurgence of whooping cough is an ongoing concern in the U.S., and this week the FDA cleared Adacel as first Tdap vaccine for repeat vaccination. Plus, Cabometyx gains a new use in aggressive liver cancer. Researchers at Georgia Tech are using microneedle techniques to develop birth control, and a reality check on cervical cancer screening is posted. Finally, first-time generics, like Teva’s newly approved seizure drug vigabatrin, are a top FDA priority.
top of page
Search
Recent Posts
See AllToday, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate...
64
bottom of page
Comments